| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 367.20B | 401.90B | 321.68B | 328.96B | 436.39B | 418.26B |
| Gross Profit | 367.19B | 401.84B | 321.67B | 301.03B | 406.09B | 378.77B |
| EBITDA | 144.44B | 60.21B | 314.87B | 320.92B | 38.77B | 37.05B |
| Net Income | 47.71B | 44.96B | 27.26B | 37.38B | 26.83B | 24.58B |
Balance Sheet | ||||||
| Total Assets | 3.03T | 2.83T | 2.34T | 2.18T | 1.95T | 1.77T |
| Cash, Cash Equivalents and Short-Term Investments | 46.40B | 29.36B | 30.93B | 748.22B | 677.93B | 617.04B |
| Total Debt | 11.90B | 13.01B | 13.38B | 12.72B | 13.10B | 13.42B |
| Total Liabilities | 2.72T | 2.52T | 2.08T | 1.94T | 1.71T | 1.55T |
| Stockholders Equity | 281.87B | 291.42B | 249.59B | 228.45B | 226.74B | 215.22B |
Cash Flow | ||||||
| Free Cash Flow | 141.60B | 150.53B | 133.88B | 138.81B | 104.72B | 104.44B |
| Operating Cash Flow | 120.50B | 154.40B | 137.86B | 147.91B | 108.41B | 108.06B |
| Investing Cash Flow | -263.50B | -209.90B | -161.36B | -168.98B | -66.09B | -136.07B |
| Financing Cash Flow | 81.75B | 61.34B | 3.29B | 28.48B | -31.37B | 21.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | HK$202.54B | 4.72 | 34.37% | 5.94% | 49.90% | 203.77% | |
78 Outperform | $389.16B | 6.31 | 17.34% | 2.98% | 9.40% | 79.93% | |
76 Outperform | $352.34B | 5.36 | 18.41% | 3.65% | 15.08% | 23.13% | |
72 Outperform | $1.10T | 6.75 | 14.53% | 4.82% | 10.20% | 19.74% | |
71 Outperform | $65.16B | 7.97 | 10.74% | 1.86% | 23.64% | 36.32% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $460.79B | 16.63 | 10.17% | 2.05% | 62.72% | 29.18% |
China Pacific Insurance (Group) Co., Ltd. announced that its subsidiary, China Pacific Life Insurance Co., Ltd., achieved a primary premium income of RMB241.322 billion from January to October 2025, marking a 9.9% increase year-on-year. Meanwhile, China Pacific Property Insurance Co., Ltd. reported a primary premium income of RMB173.567 billion, a slight increase of 0.4% compared to the previous year. These figures, although unaudited, indicate a positive growth trajectory for the company’s life insurance segment, while the property insurance segment shows modest growth, potentially impacting the company’s market positioning and stakeholder confidence.
The most recent analyst rating on (HK:2601) stock is a Buy with a HK$34.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. announced its unaudited financial results for the third quarter of 2025, showing a substantial increase in operating income and profit before tax compared to the previous year. The company’s net profit grew by 35.2% for the quarter and 19.3% for the nine months ending September 2025, indicating strong financial performance. The report highlights a notable one-time profit impact due to the inclusion of Shanghai Ruiyongjing Real Estate Development Co., Ltd. as a subsidiary, which contributed significantly to the non-recurring profit. These results reflect the company’s robust operational capabilities and its strategic positioning in the market, potentially enhancing stakeholder confidence.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$35.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. is a leading provider of life and property insurance services in China, known for its comprehensive insurance solutions and strategic focus on customer-centric transformation.
China Pacific Insurance (Group) Co., Ltd. has released an overseas regulatory announcement in compliance with the Hong Kong Stock Exchange’s listing rules. The announcement, signed by Chairman Fu Fan, includes a summary of the third quarter solvency report for Pacific Health Insurance Co., Ltd., indicating the company’s ongoing regulatory transparency and commitment to maintaining solvency standards.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$35.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. has released an overseas regulatory announcement in accordance with the Hong Kong Stock Exchange’s listing rules. The announcement, which includes a summary of the quarterly solvency report for Pacific Anxin Agricultural Insurance Co., Ltd. for the third quarter of 2025, is intended for informational purposes, reflecting the company’s commitment to transparency and regulatory compliance.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$35.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. has released an overseas regulatory announcement in compliance with Hong Kong Stock Exchange rules. The announcement, dated October 31, 2025, includes a summary of the company’s quarterly solvency report for the third quarter of 2025, providing insights into the company’s financial health and regulatory compliance.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$35.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. has released an overseas regulatory announcement in compliance with the Hong Kong Stock Exchange’s listing rules. The announcement includes a summary of the company’s quarterly solvency report for the third quarter of 2025, providing stakeholders with insights into the company’s financial health and regulatory compliance.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$35.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. has released its unaudited financial results for the third quarter of 2025, showing significant growth in key financial metrics. The company reported a 24.6% increase in operating income and an 85.7% rise in profit before tax compared to the same period in 2024. The net profit for the quarter rose by 35.2%, reflecting strong operational performance. The results indicate a robust financial position, with total assets increasing by 8.6% since the end of 2024. The inclusion of Shanghai Ruiyongjing Real Estate Development Co., Ltd. as a subsidiary contributed a one-time profit impact, enhancing the company’s financial standing.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$35.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. has announced a voluntary presentation of its 2025 third quarter results, scheduled for October 30, 2025. This initiative aims to provide investors with a comprehensive understanding of the company’s financial performance and operational status, with the Chairman and senior management available to address investor queries during a live streaming session.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$35.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. announced that its board of directors will meet on 30 October 2025 to consider and approve the company’s third quarterly results for the nine months ended 30 September 2025. This meeting is significant for stakeholders as it will provide insights into the company’s financial performance and strategic direction for the remainder of the year.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$35.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. announced that its subsidiary, China Pacific Life Insurance Co., Ltd., reported an accumulated primary premium income of RMB232.436 billion for the period from January to September 2025, marking a 10.9% year-on-year increase. Meanwhile, China Pacific Property Insurance Co., Ltd., another subsidiary, achieved a primary premium income of RMB159.955 billion, reflecting a marginal increase of 0.1% compared to the previous year. These figures, although unaudited, indicate a robust growth in the life insurance segment, while the property insurance segment shows stability. This announcement underscores the company’s strong performance and strategic positioning in the competitive insurance market.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$35.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. announced its accumulated primary premium income for the period between January and August 2025. The life insurance subsidiary reported a 13.2% year-on-year increase to RMB217.050 billion, while the property insurance subsidiary saw a 0.4% increase to RMB142.809 billion. This growth in premium income reflects the company’s strong market position and potential positive implications for stakeholders.
The most recent analyst rating on (HK:2601) stock is a Buy with a HK$40.50 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. has successfully completed the issuance of zero-coupon convertible bonds worth HK$15,556,000,000, with the listing on the Hong Kong Stock Exchange expected to be effective on 19 September 2025. The proceeds from this issuance will be used to develop the company’s insurance business, implement strategic initiatives in health services, AI, and internationalization, and for general corporate purposes, including supplementing working capital.
The most recent analyst rating on (HK:2601) stock is a Buy with a HK$40.50 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. announced its participation in the 2025 Listed Company Collective Reception Day in Shanghai and Interim Results Presentation Event. This initiative aims to strengthen communication with investors, allowing them to engage with the company’s senior management on topics such as interim results, corporate governance, and development strategies, thereby enhancing transparency and investor relations.
The most recent analyst rating on (HK:2601) stock is a Buy with a HK$40.50 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. announced the proposed issuance of HK$15.556 billion zero coupon convertible bonds due 2030 under a general mandate. The proceeds from this issuance are intended to support the company’s insurance business development, strategic initiatives in health services and AI, and general corporate purposes. The bonds are convertible into H Shares, with the initial conversion price set at HK$39.04 per share, representing a significant potential increase in share capital. The issuance is subject to certain conditions and regulatory approvals, and the company advises caution to shareholders and potential investors regarding the completion of this transaction.
The most recent analyst rating on (HK:2601) stock is a Buy with a HK$40.50 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. has announced a proposed issuance of HKD-denominated convertible bonds aimed at professional investors outside the United States, in accordance with Regulation S under the Securities Act. The proceeds from this issuance are intended to support the development of the company’s insurance business, strategic initiatives in health services and elderly care, AI+, internationalization, and general corporate purposes. The issuance is subject to market conditions and no definitive agreement has been reached yet, urging potential investors and shareholders to exercise caution.
The most recent analyst rating on (HK:2601) stock is a Buy with a HK$40.50 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd., also known as China Pacific Insurance, is a major player in the insurance sector, offering a range of life and property insurance products across China and internationally. The company is listed on the Shanghai, Hong Kong, and London stock exchanges, reflecting its significant presence in the financial markets.
China Pacific Insurance (Group) Co., Ltd. held its first extraordinary general meeting (EGM) for 2025, where shareholders voted on a special resolution regarding the proposed dissolution of the Board of Supervisors. The resolution was passed with over two-thirds majority, indicating strong shareholder support for the change. This decision could potentially impact the company’s governance structure and future strategic direction.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$29.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. has issued an overseas regulatory announcement in compliance with the Hong Kong Stock Exchange’s listing rules. The announcement, which includes a summary of the company’s quarterly solvency report for the second quarter of 2025, is intended for informational purposes and reflects the company’s commitment to transparency and regulatory compliance.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$29.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. has released an overseas regulatory announcement in compliance with the listing rules of the Hong Kong Stock Exchange. The announcement includes a summary of the company’s quarterly solvency report for the second quarter of 2025, which is crucial for stakeholders to assess the company’s financial health and regulatory compliance.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$29.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. announced the resignation of Mr. ZHU Yonghong from his roles as chairman of the board of supervisors and shareholder representative supervisor, effective August 27, 2025, due to changes in his work arrangements. His departure will not affect the board’s operations or quorum. Mr. ZHU’s tenure was marked by significant contributions to corporate governance and financial oversight, enhancing the company’s supervisory framework and stakeholder rights.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$29.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. has released its 2025 interim results, highlighting its ongoing regulatory compliance and corporate governance. This announcement underscores the company’s commitment to transparency and its strategic positioning within the insurance sector, potentially impacting stakeholders’ confidence and market perception.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$29.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. has released an overseas regulatory announcement in compliance with the Hong Kong Stock Exchange’s listing rules. This announcement, dated August 29, 2025, provides stakeholders with interim solvency report excerpts, reflecting the company’s regulatory adherence and financial transparency.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$29.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. has released an overseas regulatory announcement in compliance with Hong Kong Stock Exchange’s listing rules. The announcement includes a summary of the quarterly solvency report for Pacific Anxin Agricultural Insurance Co., Ltd. for the second quarter of 2025, highlighting the company’s adherence to regulatory requirements and providing insights into its financial health.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$29.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. has released an overseas regulatory announcement in compliance with the Hong Kong Stock Exchange’s listing rules. This announcement, dated August 29, 2025, includes a summary of the quarterly solvency report for Pacific Health Insurance Co., Ltd. for the second quarter of 2025, which is intended for informational purposes. The release underscores the company’s adherence to regulatory requirements and provides stakeholders with insights into its financial health and operational transparency.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$29.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
In the first half of 2025, China Pacific Insurance (Group) Co., Ltd. reported a stable growth in its financial performance despite global economic challenges. The company achieved a 3.0% increase in group operating income and a 3.5% rise in insurance revenue. The company optimized its core business mix, resulting in improved operational resilience and profitability. The life insurance segment saw rapid growth in new business value, while the property and casualty segment experienced significant growth in underwriting profit. The health insurance segment capitalized on the integration of social and private insurance, promoting product innovation. These developments reflect the company’s commitment to high-quality development and strengthening its market position.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$29.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
China Pacific Insurance (Group) Co., Ltd. announced it will disclose its 2025 interim results on August 28, 2025, with a presentation scheduled for August 29, 2025, to provide investors with a comprehensive understanding of its performance. The presentation will feature the company’s president and senior management, who will address investor questions submitted in advance, indicating a commitment to transparency and engagement with stakeholders.
The most recent analyst rating on (HK:2601) stock is a Hold with a HK$29.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.